HON
47
-12
FLR
52
4
OI
43
-7
CNX
80
4
CVS
45
-4
THC
61
-3
MAS
67
-3
MMM
52
2
AVY
53
-9
UNP
40
-2
FOXA
48
7
WEC
45
2
MUR
50
-2
STT
51
-5
DNB
50
-4
IP
39
-6
HAS
55
-2
DHI
53
-3
NTRS
49
-5
AIV
71
9
HON
47
-12
FLR
52
4
OI
43
-7
CNX
80
4
CVS
45
-4
THC
61
-3
MAS
67
-3
MMM
52
2
AVY
53
-9
UNP
40
-2
FOXA
48
7
WEC
45
2
MUR
50
-2
STT
51
-5
DNB
50
-4
IP
39
-6
HAS
55
-2
DHI
53
-3
NTRS
49
-5
AIV
71
9
Financhill
Back

Bank of New York Mellon Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
74

BK
Bank of New York Mellon

Last Price:
71.79
Seasonality Move:
2.83%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
74
Bank of New York Mellon (BK) is a Buy

Is Bank of New York Mellon a Buy, Sell or Hold?

  • The current Bank of New York Mellon [BK] share price is $71.82. The Score for BK is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • BK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BK Stock Price Chart

What is Bank of New York Mellon's stock price today?

  • The Bank of New York Mellon share price today is $71.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BK is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.69 Buy
Relative Strength Index (14 RSI): 75.03 Buy
Chaikin Money Flow: 5468936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.96 - 69.84) Buy
Bollinger Bands (100): (58.36 - 66.42) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

BK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.22 Buy
20-day SMA: 68.5 Buy
50-day SMA: 65.9 Buy
200-day SMA: 58.47 Buy
8-day EMA: 70.41 Buy
20-day EMA: 68.69 Buy
50-day EMA: 66.05 Buy
200-day EMA: 58.97 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Bank of New York Mellon Earnings Growth & BK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.25 per share, an increase this year of $0.75 per share, and an increase next year of $0.64 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Bank of New York Mellon Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):